Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia (Q33401766)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia |
scientific article |
Statements
1 reference
Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia (English)
1 reference
Hagop M Kantarjian
1 reference
Anna Dmoszynska
1 reference
Stefan Faderl
1 reference
Farhad Ravandi
1 reference
Agnieszka Wierzbowska
1 reference
Jacques Delaunay
1 reference
Mark Minden
1 reference
Rena Buckstein
1 reference
Xavier G Thomas
1 reference
Grzegorz Mazur
1 reference
Jiri Mayer
1 reference
Jyh-Pyng Gau
1 reference
Jaroslav Cermak
1 reference
Ching-Yuan Kuo
1 reference
Daniel Lysák
1 reference
Christopher Arthur
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference